Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice

Abstract Human malaria affects the vast majority of the world’s population with the Plasmodium falciparum species causing the highest rates of morbidity and mortality. With no licensed vaccine and leading candidates achieving suboptimal protection in the field, the need for an effective immunoprophy...

Full description

Bibliographic Details
Published in:	npj Vaccines
Main Authors:	Katherine L. Mallory, Justin A. Taylor, Xiaoyan Zou, Ishita N. Waghela, Cosette G. Schneider, Michael Q. Sibilo, Neeraja M. Punde, Leah C. Perazzo, Tatyana Savransky, Martha Sedegah, Sheetij Dutta, Chris J. Janse, Norbert Pardi, Paulo J. C. Lin, Ying K. Tam, Drew Weissman, Evelina Angov
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-06-01
Online Access:	https://doi.org/10.1038/s41541-021-00345-0

Similar Items

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
by: Clifford T. H. Hayashi, et al.
Published: (2022-12-01)

iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA
by: Sean Yanik, et al.
Published: (2025-02-01)

Author Correction: mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
by: Clifford T. H. Hayashi, et al.
Published: (2023-08-01)

Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9
by: Gregory M. Martin, et al.
Published: (2023-05-01)

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
by: Julia Ludwig, et al.
Published: (2023-04-01)

Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection
by: Gregory M. Martin, et al.
Published: (2023-07-01)

Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model
by: Julia Ludwig, et al.
Published: (2023-06-01)

Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
by: Ishita N. Waghela, et al.
Published: (2022-12-01)

Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
by: Natasha KC, et al.
Published: (2022-10-01)

PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies
by: John M. Hickey, et al.
Published: (2025-12-01)

Humoral Immune Responses to P. falciparum Circumsporozoite Protein (Pfcsp) Induced by the RTS, S Vaccine – Current Update
by: Ngulube P
Published: (2023-04-01)

Orientation of Antigen Display on Self-Assembling Protein Nanoparticles Influences Immunogenicity
by: Cosette G. Schneider, et al.
Published: (2021-01-01)

CSP Data: A Data Discovery Web Application of Commercial CSP Plants
by: Javier Bonilla, et al.
Published: (2024-07-01)

Potensi vaksinasi P. Falciparum circumsporozoite protein adjuvan CAF09 (PF CSP-CAF09) untuk pencegahan malaria dengan induksi sel t CD8+
by: Fandy Ong Jaya, et al.
Published: (2023-01-01)

CSP 40 anos: maturidade
by: Marilia Sá Carvalho, et al.
Published: (2024-01-01)

CSPα in neurodegenerative diseases
by: Liqin Huang, et al.
Published: (2022-11-01)

Concentrating Solar Power (CSP) Plant Optimization Study for the California Power Market (CalCSP)
by: Hank Price, et al.
Published: (2024-03-01)

DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.
by: Ilin Chuang, et al.
Published: (2013-01-01)

Messiahs and Their Messengers
by: Matthew V. Novenson
Published: (2019-10-01)

SDPs and Robust Satisfiability of Promise CSP
by: Joshua Brakensiek, et al.
Published: (2025-09-01)

ACWA Power’s CSP Performance Assessment
by: Oliver Vorbrugg, et al.
Published: (2024-08-01)

Artificial intelligence and editorial process in CSP
by: Luciana Correia Alves, et al.
Published: (2024-11-01)

Modeling the Guaranteed Performance of CSP Plants
by: Hank Price, et al.
Published: (2024-02-01)

ACWA Power’s CSP Performance Models
by: Jose Maria Barea, et al.
Published: (2024-09-01)

Transition metal-free Csp3-Csp3 bond-forming reactions of N-tosylaziridines and gem-diborylalkanes
by: Pu-Zhang Zi, et al.
Published: (2024-11-01)

Michel Serres’ Messengers
by: Timothy Barker
Published: (2021-09-01)

Messenger in der Schule
by: Philip Karsch
Published: (2023-08-01)

Don't shoot the messenger!
by: Keith A. Hobson, et al.
Published: (2015-12-01)

Leaf-like CuO nanosheets on rGO as an efficient heterogeneous catalyst for Csp-Csp homocoupling of terminal alkynes
by: Bin Wang, et al.
Published: (2021-02-01)

COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on 68Ga-DOTATATE positron-emission tomography/computed tomography
by: Joshua Weissman, et al.
Published: (2021-10-01)

Scientific dissemination in CSP: importance, advances, and challenges
by: Luciana Dias de Lima, et al.
Published: (2025-01-01)

Basic Techniques for Creating an Efficient CSP Solver
by: C. Frăsinaru
Published: (2007-12-01)

Atenção primária à saúde em CSP
by: Patty Fidelis de Almeida, et al.
Published: (2022-08-01)

CSP: bem comum da Saúde Coletiva
by: Marilia Sá Carvalho, et al.
Published: (2017-08-01)

Fast-track COVID-19 em CSP
by: Marilia Sá Carvalho, et al.

Palladium‐Catalyzed Dual Csp2─Csp3 Bond Formation: A Versatile Platform for the Synthesis of Benzo‐Fused Heterocycles
by: Jiahui Huang, et al.
Published: (2025-07-01)

Cellular RNA Targets of Cold Shock Proteins CspC and CspE and Their Importance for Serum Resistance in Septicemic Escherichia coli
by: Yael Yair, et al.
Published: (2022-08-01)

Plasmodium falciparum AMA1 and CSP antigen diversity in parasite isolates from southern Ghana
by: Kwadwo A. Kusi, et al.
Published: (2024-05-01)

IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
by: Robert Schwenk, et al.
Published: (2014-01-01)

Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice.
by: Rhea J Longley, et al.
Published: (2015-01-01)